Association between the TP53 polymorphisms and lung cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 41, Issue 1, 2014, Pages 373-385

  Ye, Xiang Hua ^a   Bu, Zhi Bin ^b   Feng, Jie ^c   Peng, Ling ^a   Liao, Xin Biao ^a   Zhu, Xin Li ^a   Sun, Xiao Li ^a   Yu, Hao Gang ^a   Yan, Dan Fang ^a   Yan, Sen Xiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG HOSPITAL   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; Meta analysis; Polymorphism; TP53

Indexed keywords

PROTEIN P53;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; CODON; DISEASE ASSOCIATION; ETHNICITY; GENE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INTRON; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; META ANALYSIS (TOPIC); SENSITIVITY ANALYSIS; TP53 GENE;

CASE-CONTROL STUDIES; CODON; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84891928097     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2871-1     Document Type: Article

References (72)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Alberg AJ, Brock MV, Samet JM (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23:3175-3185
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
4. Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10:431-442
5. Denehower LA (2005) p53 guardian and suppressor of longevity? Exp Gerontol 40:7-9
6. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365
7. Runnebaum IB, Tong XW, Moebus V, Heilmann V, Kieback DG, Kreienberg R (1994) Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines. Hum Genet 93:620-624
8. Lazar V, Hazard F, Bertin F, Janin N, Bellet D, Bressac B (1993) Simple sequence repeat polymorphism within the p53 gene. Oncogene 8:1703-1705
9. Chumakov PM, Jenkins JR (1991) BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res 19:6969
10. Mattick JS (1994) Introns: evolution and function. Curr Opin Genet Dev 4:823-831
11. Weston A, Perrin LS, Forrester K, Hoover RN, Trump BF, Harris CC (1992) Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev 1:481-483
12. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14:1085-1089
13. Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF, Harris CC (1994) Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15:583-587
14. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR (1995) Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16:2205-2208
15. Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Beckman G, Beckman L (1995) P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16:2233-2236
16. To-Figueras J, Gene M, Gomez-Catalan J, Galan C, Firvida J, Fuentes M, Rodamilans M, Huguet E, Estape J, Corbella J (1996) Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5:337-342
17. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H (1996) Analysis of a germ line polymorphism of the p53 gene in lung cancer patients discrete results with smoking history. Carcinogenesis 17:261-264
18. Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T (1998) Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small lung cancer patients. Int J Oncol 12:577-581
19. Wang YC, Chen CY, Chen SK, Chang YY, Lin P (1999) P53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5:129-134
20. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK (2000) The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9:1037-1042
21. Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A (2000) Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev 9:1199-1204
22. Biros E, Kalina I, Biros I, Kohut A, Bogyiova E, Salagovic J (2001) Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma 48:407-411
23. Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL (2001) Differential association of the codon 72 p53 and GSTM1 polymorphisms on the histological subtype of non-small cell lung carcinoma. Cancer Res 61:8718-8722
24. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK (2002) P53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94:681-690
25. Miller DP, Liu G, De L, Lynch TJ, Wain JC, Su L (2002) Combinations of the variant genotypes of GSTP1, GSTM1 and p53 are associated with an increased lung cancer risk. Cancer Res 62:2819-2823
26. Papadakis ED, Soulitzis N, Spandidos DA (2002) Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 87:1013-1018
27. Irarrazabal CE, Rojas C, Aracena R, Marquez C, Gil L (2003) Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett 144:69-76
28. Hiraki A, Matsuo K, Hamajima N, Ito H, Hatooka S, Suyama M (2003) Different risk relations with smoking for non-small-cell lung cancer: comparison of P53 and TP73 genotypes. Asian Pac J Cancer Prev 4:107-112
29. Zhang JH, Li Y, Wang R, Wen DG, Wu ML, He M (2003) P53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population. Zhonghua zhong liu za zhi 25:365-367
30. Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC (2003) P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer 40:259-266
31. Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R (2005) Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128:3999-4007
32. Sakiyama T, Kohno T, Mimaki S, Ohta T, Yanagitani N, Sobue T, Kunitoh H (2005) Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 114:730-737
33. Zhang XM, Miao X, Guo Y, Tan W, Zhou Y, Sun T (2006) Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat 27:110-117
34. Hung RJ, Boffetta P, Canzian F, Moullan N, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V (2006) Sequence variants in cell cycle control pathway X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe. Cancer Res 66:8280-8286
35. Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G (2006) Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 52:9-14
36. Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T (2007) Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Lung Cancer 55:25-34
37. Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, Dantonio D (2007) Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57:273-281
38. Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L (2007) Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev 16:214-222
39. Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y (2007) An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 56:145-151
40. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X (2007) Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res 13:5974-5981
41. Sreeja L, Syamala V, Raveendran PB, Santhi S, Madhavan J, Ankathil R (2008) p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Cancer Invest 26:41-46
42. Fernández-Rubio A, López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Tardón A (2008) The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. Lung Cancer 61:309-316
43. Honma HN, De Capitani EM, Perroud MW, Barbeiroa AS, Toro IF, Costa DB (2008) Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer 62:152-162
44. Jung HY, Whang YM, Sung JS, Shin HD, Park BL, Kim JS (2008) Association study of TP53 polymorphisms with lung cancer in a Korean population. J Hum Genet 53:508-514
45. Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, Raimondi S (2009) Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA Cell Biol 28(9):443-449
46. Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk W, Cressey R (2009) Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet 195:143-149
47. Cáceres DD, Quiñones LA, Schroeder JC, Gil LD, Irarrázabal CE (2009) Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk. Lung 187(2):110-115
48. Kiyohara C, Horiuchi T, Miyake Y, Takayama K, Nakanishi Y (2010) Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. Oncol Rep 23(5):1361-1368
49. Pandima Devi K, Sivamaruthi B, Kiruthiga PV, Karutha Pandian S (2010) Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits. Hum Exp Toxicol 29:451-458
50. Chua HW, Ng D, Choo S, Lum SS, Li H, Soh LY, Sabapathy K, Seow A (2010) Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore. BMC Cancer 10:88
51. Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y, Phukan R, Mahanta J, Kataki AC, Kapur S, Saxena S (2011) Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol 30:163-171
52. Biros E, Kalina I, Kohut A, Stubna J, Salagovic J (2001) Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer 31:157-162
53. Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR (2006) Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev 15(1):158-161
54. Kohno T, Kunitoh H, Mimaki S, Shiraishi K, Kuchiba A, Yamamoto S, Yokota J (2011) Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol 6:813-817
55. Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH (2011) p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. Lung Cancer 73:264-267
56. Liu D, Wang F, Guo X, Wang Q, Wang W, Xu H, Xu G (2012) Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population. Mol Biol Rep 40(1):645-649
57. Davey SG, Egger M (1997) Meta-analyses of randomized controlled trials. Lancet 350:1182
58. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37:120-132
59. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
60. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
61. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443-3457
62. Robles AI, Linke SP, Harris CC (2002) The p53 network in lung carcinogenesis. Oncogene 21:6898-6907
63. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100
64. Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9:95-107
65. Pietsch EC, Humbey O, Murphy ME (2006) Polymorphisms in the p53 pathway. Oncogene 25:1602-1611
66. Hrstka R, Coates PJ, Vojtesek B (2009) Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. J Cell Mol Med 13:440-453
67. Sato S, Nakamura Y, Tsuchiya E (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54:5652-5655
68. Matakidou A, Eisen T, Houlston RS (2003) TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18:377-385
69. Li Y, Qiu LX, Shen XK, Lv XJ, Qian XP, Song Y (2009) A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer 66:15-21
70. Dai S, Mao C, Jiang L, Wang G, Cheng H (2009) P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum Genet 125:633-638
71. Yan L, Zhang D, Chen C, Mao Y, Xie Y, Li Y, Huang Y, Han B (2009) TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. Int J Cancer 125:2903-2911
72. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11:730-738